JPRN-UMIN000021870
Recruiting
N/A
Clinical trial of concurrent chemoradiotherapy (CCRT) with S-1 in patients with advanced head and neck squamous cell carcinoma, who is not eligible for CCRT with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) regimen - Clinical trial of concurrent chemoradiotherapy with S-1 in patients with advanced head and neck squamous cell carcinoma
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- advanced head and neck squamous cell carcinoma
- Sponsor
- Yokohama City University hospital
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. with active double cancer 2\. with sever complications (for example ; malignant hypertension, congested heart failure, coronary insufficiency, myocardial infarction, angina pectoris, or abnormal cardiac rhythm which need to treat within 6 months, cerebrovascular accident within 6 months, cirrhosis, hemorrhagic gastrointestinal ulceration, diabetes that is loss of control, bleeding tendency) 3\. with deverop fever and suspected infection 4\. with motor palsy, peripheral neuropathy or edema (exclude the disorder which derives from primary disease) 5\. with pleural effusion which need to treat or pericardial effusions 6\. pregnant or nursing women or women who like be pregnant 7\. with interstitial pneumonitis which is revealed from chest X ray or chest CT 8\. with a history of mental disorder or treated it at the momen 9\. with a history of sever drug allergy 10\. with sever allergy to S\-1 11\. during any treatment with other pyrimidine analogue drug 12\. during any treatment with Flucytosine 13\. Physician concludes that the patient\&\#39;s participation in this trial is inappropriate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
phase II trial of concurrent chemoradiotherapy (CCRT) with docetaxel + cisplatin + cetuximab for locally advanced squamous cell carcinoma of the head and neckadvanced squamous cell carcinoma of the head and neckJPRN-UMIN000013858Department of Biology and Function in the Head and Neck, Yokohama City University Graduate School of Medicine30
Recruiting
N/A
Clinical trial of concurrent chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in patients with locally advanced head and neck squamous cell carcinomaocally advanced head and neck squamous cell carcinomaJPRN-UMIN000021841Yokohama City University hospital50
Completed
Phase 2
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophaguscervical esophageal cancerJPRN-UMIN000001439ational Cancer Center Hospital32
Completed
Phase 2
Phase II study of Concurrent Chemoradiotherapy using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma: Kitasato Gynecologic Radiation Oncology Group 0501 (KGROG0501)ocally Advanced Uterine Cervical CarcinomaJPRN-UMIN000025688Kitasato Gynecologic Radiatoin Oncology Group (KGROG)45
Completed
Phase 3
A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)anal canal canerJPRN-UMIN000003237Japan Clinical Oncology Group(JCOG)71